A phase I/II, two-arm, multicenter, dose escalation study of oral AEE788 administered on a continuous once daily dosing schedule in adult patients with recurrent or relapsing glioblastoma multiforme.

Trial Profile

A phase I/II, two-arm, multicenter, dose escalation study of oral AEE788 administered on a continuous once daily dosing schedule in adult patients with recurrent or relapsing glioblastoma multiforme.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 11 Nov 2015

At a glance

  • Drugs AEE 788 (Primary)
  • Indications Glioblastoma
  • Focus Adverse reactions
  • Most Recent Events

    • 05 Jul 2007 Status changed from in progress to completed.
    • 02 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top